Clinical trial
Relationship Among Changes in Brain Network Activation, Changes in Core Depressive and Cognitive Symptoms and Safety and Tolerability in Adults With Major Depressive Disorder Treated With Open-Label, Flexible-Dose Vortioxetine
NCT02749721 is registered in ClinicalTrials.gov with Rush University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Relationship Among Changes in Brain Network Activation, Changes in Core Depressive and Cognitive Symptoms and Safety and Tolerability in Adults With Major Depressive Disorder Treated With Open-Label, Flexible-Dose Vortioxetine
- Lead sponsor
- Rush University Medical Center
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- December 31, 2016
- Completion date
- January 31, 2019
- Enrollment
- 31 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.